VG
Vijendra Gairola
About Vijendra Gairola
Data last updated:
Vijendra Gairola has 11 years in corporate governance. Holds Director and Managing Director roles. Currently with 6 companies, including Induscann Biogrowth Private Limited and Induscann Research Private Limited. Formerly with 6 companies, such as Vamana Extrusions Private Limited and Galen Biopharma India Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹1.50 Cr; the largest is Novel Structural Developers Private Limited at ₹99.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novel Structural Developers Private Limited U45201MH2018PTC317709 | Director | 30 Nov 2018 | 2018 | ₹99.9 Lakh (FY 2025) | Active |
 Induscann Research Private Limited U01409MH2019FTC320446 | Director | 31 Jan 2019 | 2019 | ₹21.2 Lakh (FY 2022) | Active |
 Induscann Biogrowth Private Limited U01110GA2020PTC014416 | Director | 14 Jul 2020 | 2020 | ₹19.2 Lakh (FY 2022) | Active |
| Novel Assembler Private Limited U45100MH2018PTC314660 | Managing Director | 24 Sep 2018 | 2018 | ₹10 Lakh (FY 2025) | Active |
| Pan India Medical Cannabis And Hemp Association U85300MH2021NPL373968 | Director | 21 Mar 2022 | 2021 | ₹10,000 (FY 2025) | Active |
| Jam Sustainable Housing Llp AAR-4657 | Partner | 30 Dec 2019 | 2019 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Vamana Extrusions Private Limited U74999TN2016PTC104809 | Director | 24 Nov 2017 | 2016 | ₹11.7 Lakh (FY 2020) | Active |
| Galen Biopharma India Private Limited U73100MH2020PTC342833 | Director | 28 Jul 2020 | 2020 | – | Strike Off |
| Novel Building Technologies Private Limited U45201MH2016FTC289019 | Whole-Time Director | 28 Dec 2016 | 2016 | ₹5.27 Cr (FY 2019) | Active |
| Anandamide Research India Private Limited U73100MH2019FTC324408 | Director | 22 Apr 2019 | 2019 | – | Strike Off |
| Maple Inca Synergies Private Limited U74120MH2015PTC261201 | Director | 21 Jan 2015 | 2015 | – | Strike Off |
| Novel Extrusions Private Limited U74999MH2018PTC316609 | Director | 31 Oct 2018 | 2018 | ₹2,314 (FY 2020) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijendra Gairola
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijendra Gairola
Vijendra Gairola has 11 years in corporate governance. Holds Director and Managing Director roles. Currently with 6 companies, including Induscann Biogrowth Private Limited and Induscann Research Private Limited. Formerly with 6 companies, such as Vamana Extrusions Private Limited and Galen Biopharma India Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 5 current companies with reported revenue have a combined latest revenue of ₹1.50 Cr; the largest is Novel Structural Developers Private Limited at ₹99.9 Lakh (FY 2025).
Vijendra Gairola is associated with 6 companies as Director and Managing Director, including Novel Structural Developers Private Limited (₹99.9 Lakh), Induscann Research Private Limited (₹21.2 Lakh), Induscann Biogrowth Private Limited (₹19.2 Lakh).
Vijendra Gairola has expertise in General Business, Technology.
Vijendra Gairola has 11 years in corporate governance.
By reported revenue, the largest current company of Vijendra Gairola is Novel Structural Developers Private Limited, with revenue of ₹99.9 Lakh (FY 2025).
The 5 current companies of Vijendra Gairola that report revenue have a combined latest revenue of ₹1.50 Cr.
Vijendra Gairola currently holds positions at 6 companies; the 5 largest by reported revenue are Novel Structural Developers Private Limited (₹99.9 Lakh), Induscann Research Private Limited (₹21.2 Lakh), Induscann Biogrowth Private Limited (₹19.2 Lakh), Novel Assembler Private Limited (₹10 Lakh), Pan India Medical Cannabis And Hemp Association (₹10,000).